Enabling quicker research, development, and production for upstream bioprocessing through scale out Like the cells they culture, bioreactors come in various shapes, sizes, and specialties. While they ...

Although bioreactor scale-up often involves matching key engineering parameters, a biology-first approach should dictate the process.

This presentation takes a deep dive into the development and manufacturing of monoclonal antibodies (mAbs). We’ll explore a successful study from MacroGenics, highlighting their process development, ...

SAN DIEGO, CA / ACCESS Newswire / May 27, 2025 / Bora Biologics, a leading contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, announced a major ...

Upstream process intensification using perfusion cell culture has become a necessity for meeting today’s demand in monoclonal antibodies (mAbs) bioprocessing. By sustaining higher viable cell ...